Dalbavancin: a new option for the treatment of gram-positive infections.
about
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United StatesInvestigational treatments for postoperative surgical site infections.Antimicrobial therapy of Staphylococcus aureus bloodstream infection.Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.Dalbavancin (zeven), a novel glycopeptide for resistant gram-positive organisms.
P2860
Q35690571-701D6088-9E10-4ADA-B79E-1589F733B0D6Q36715742-DA4BAFA0-1C15-48BC-92E6-E0F251EC544BQ36968150-88B32E00-C0A5-4B5E-9675-E75F3738EFF0Q37077627-8D4FA0EE-888A-4AE9-99EB-BC5F67D6707EQ37785546-1FFF5883-CA65-4488-B35E-CDCBAAEF86CEQ41958813-2BDD056E-2399-48A0-A8AA-3F945D0FC652Q43066197-D717F541-D46B-44AD-A5CA-ED5B3ABDC7AF
P2860
Dalbavancin: a new option for the treatment of gram-positive infections.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Dalbavancin: a new option for the treatment of gram-positive infections.
@ast
Dalbavancin: a new option for the treatment of gram-positive infections.
@en
type
label
Dalbavancin: a new option for the treatment of gram-positive infections.
@ast
Dalbavancin: a new option for the treatment of gram-positive infections.
@en
prefLabel
Dalbavancin: a new option for the treatment of gram-positive infections.
@ast
Dalbavancin: a new option for the treatment of gram-positive infections.
@en
P2093
P2860
P356
P1476
Dalbavancin: a new option for the treatment of gram-positive infections.
@en
P2093
Daryl D DePestel
Peggy L Carver
Shu-Wen Lin
P2860
P304
P356
10.1345/APH.1G158
P407
P577
2006-02-28T00:00:00Z